Previous Article | Next Article ![]()
Molecular and Cellular Biology, December 2006, p. 8814-8825, Vol. 26, No. 23
0270-7306/06/$08.00+0 doi:10.1128/MCB.00636-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
,
Christopher H. Eskiw,
Graham Dellaire, and
David P. Bazett-Jones*
Research Institute, The Hospital for Sick Children, Toronto, Canada
Received 12 April 2006/ Returned for modification 26 June 2006/ Accepted 30 August 2006
Whereas the PML protein has been reported to have both transcriptional coactivator and corepressor potential, the contribution of the PML nuclear body (PML NB) itself to transcriptional regulation is not well understood. Here we demonstrate that plasmid DNA artificially tethered to PML or the PML NB-targeting domain of Sp100 is preferentially localized to PML NBs. Using the tethering technique, we targeted a simian virus 40 promoter-driven luciferase reporter plasmid to PML NBs, resulting in the repression of the transgene transcriptional activity. Conversely, the tethering of a cytomegalovirus promoter-containing reporter plasmid resulted in activation. Targeting a minimal eukaryotic promoter did not affect its activity. The expression of targeted promoters could be modulated by altering the cellular concentration of PML NB components, including Sp100 and isoforms of the PML protein. Finally, we demonstrate that ICP0, the promiscuous herpes simplex virus transactivator, increases the level of transcriptional activation of plasmid DNA tethered to the PML NB. We conclude that when PML NB components are artificially tethered to reporter plasmids, the PML NB contributes to the regulation of the tethered DNA in a promoter-dependent manner. Our findings demonstrate that transient transcription assays are sensitive to the subnuclear localization of the transgene plasmid.
Published ahead of print on 11 September 2006.
Supplemental material for this article may be found at http://mcb.asm.org/.
Present address: Sir William Dunn School of Pathology, Oxford University, Oxford, United Kingdom.
Present address: Department of Gene Therapy, Tulane University, New Orleans, La.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»